Senior insider sale
Chief Executive Officer at LEGEND BIOTECH CORP — senior position signals high conviction
$2.86M
125.81K shares
What this filing means
HUANG YING plans to sell 125.81K shares of LEGEND BIOTECH CORP valued at approximately $2.86M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/29/2025ACC: 0001959173-25-007923
DirectorOfficer· Chief Executive Officer
Since Mar 2026
125.81K
Shares to sell
$2.86M
Approx. market value
64.34K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
12/20/2025
64.34KTotal acquired64.34K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/20/2025 | Restricted Stock Vesting Compensation | 64.34K | — |
| Total | 64.34K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
61.47K
Market value
$1.41M
12/24/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
64.34K
Market value
$1.45M
12/26/2025
Total
Units
125.81K
Value
$2.86M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
12/24/2025 | 61.47K | $1.41M | — | Completed |
| Planned — Approximate Date | ||||
12/26/2025 | 64.34K | $1.45M | NASDAQ | Planned |
| Total | 125.81K | $2.86M | ||